Why Is Rockwell Medical Gaining Tuesday?
I'm PortAI, I can summarize articles.
Rockwell Medical (RMTI) stock rose 22.22% to $1.17 after announcing preliminary Q4 and full-year 2025 financial results, with sales expected to reach $18.6 million, surpassing estimates of $16.55 million. Full-year revenue is projected at $69.5 million, with a gross margin of approximately 22%. The company achieved positive adjusted EBITDA and operating cash flow of about $2.3 million. CEO Mark Strobeck emphasized a focus on sales growth and profitability for 2026, despite a 56% decline in stock value over the past year.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments